RLY-2608
Product Specifications
CAS Number
2733573-94-7
Target
PI3K
Related Pathways
PI3K/Akt/mTOR signaling
Purity
0.9896
Bioactivity
RLY-2608 is a selective mutant PI3K? inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.
Smiles
N(C(=O)C1=CC(C(F)(F)F)=CC(F)=C1)C2=C3[C@@H](NC(=O)C3=CC(=C2)C4=C(C#N)N5C(C=C4)=NC=N5)C6=C(Cl)C=CC(F)=C6
Molecular Formula
C29H14ClF5N6O2
Molecular Weight
608.91
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
124461-ML490 100 µL
CCL23 (C-C Motif Chemokine 23, CK-beta-8, CKB-8, Macrophage Inflammatory Protein 3, MIP-3, Myeloid Progenitor Inhibitory Factor 1, MPIF-1, Small-inducible Cytokine A23, MIP3, MPIF1, SCYA23) (MaxLight 490)
Ask
View Details 043328 200 µL
TSC1, phosphorylated (T390) (TSC1, KIAA0243, TSC, Hamartin, Tuberous sclerosis 1 protein)
Ask
View Details 
GTR15395084 1 Vial
Lentiviral human ADGRG6 sgRNA gene knockout kit - Lentiviral human ADGRG6 sgRNA gene knockout kit (plasmid)
Ask
View Details